UNVERIFIEDSingle SourceA new trick for old science, and biotech VCs’ scrambled playbookStat News|4/9/2026
UNVERIFIEDSingle SourceEli Lilly’s deal man, Allogene’s off-the-shelf CAR-T, and Merck’s Terns buyStat News|3/26/2026
UNVERIFIEDSingle SourceEpstein’s pal attempts a biotech comeback, and Prasad exits the FDAStat News|3/12/2026
UNVERIFIEDSingle SourceSTAT+: Moderna’s president weighs in on FDA’s decision not to review its flu vaccineStat News|2/12/2026
UNVERIFIEDSingle SourceChallenges for a crucial sickle cell treatment and the latest outlook for GLP-1sStat News|2/5/2026